Intraoperative Protective Mechanical Ventilation in Patients Requiring Emergency Abdominal Surgery
NCT ID: NCT03987789
Last Updated: 2022-10-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
707 participants
INTERVENTIONAL
2021-02-18
2022-10-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intraoperative Protective Ventilation in Abdominal Surgery (IMPROVE Study)
NCT01282996
Non Invasive Ventilation in Abdominal Postoperative Period
NCT01971892
Individualized Perioperative Open Lung Ventilatory Strategy
NCT02158923
Effect of Intraoperative PEEP Individualization According to Driving Pressure in Major Abdominal Surgery
NCT05781373
Prevention of Postoperative Respiratory Complications
NCT06899295
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Two hypotheses can be forward by the literature. First, a low VT lung protective ventilation in combination with a strategy aimed at minimizing alveolar distension by using low PEEP level (and without recruitment maneuver) could improve postoperative outcome while reducing the risk of hemodynamic alterations or, second, could increase the risk of PRF compared with a strategy aimed at increasing alveolar recruitment using higher PEEP level adjusted according to driving pressure in combination with recruitment maneuvers in adult patients undergoing emergency abdominal surgery. Given the uncertainties, and in order to determine the impact of lung protective ventilation strategies on clinical outcomes of high-risk surgical patients, a randomized trial is needed.
Our primary hypothesis is that, during low VT ventilation, a strategy aimed at increasing alveolar recruitment by using high PEEP levels adjusted according to driving pressure in combination with recruitment maneuvers could be more effective at reducing PRF and mortality after emergency abdominal surgery than a strategy aimed at minimizing alveolar distension by using lower PEEP without recruitment maneuver.
Given the number of patients for whom the question applies, the prevalence and the burden of PPCs, the study can have significant clinical importance and public health implications.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low PEEP group
Patients will receive a PEEP level ≤5 cmH2O without recruitment maneuvers
Low PEEP
Patients will receive a PEEP level ≤5 cmH2O without recruitment maneuvers
Driving-pressure-guided group
Patients will receive PEEP levels individually set at the highest possible value (up to 15 cmH2O) providing a driving pressure (airway plateau pressure minus PEEP) lower than 13 cmH2O, in addition to recruitment maneuvers
Driving-pressure-guided group
Patients will receive PEEP levels individually set at the highest possible value (up to 15 cmH2O) providing a driving pressure (airway plateau pressure minus PEEP) lower than 13 cmH2O, in addition to recruitment maneuvers.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Driving-pressure-guided group
Patients will receive PEEP levels individually set at the highest possible value (up to 15 cmH2O) providing a driving pressure (airway plateau pressure minus PEEP) lower than 13 cmH2O, in addition to recruitment maneuvers.
Low PEEP
Patients will receive a PEEP level ≤5 cmH2O without recruitment maneuvers
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients requiring emergency (defined by the need to proceed to surgery within a few hours after diagnosis)
* Laparoscopic or non-laparoscopic abdominal surgery under general anesthesia and with an expected duration of at least two hours
Exclusion Criteria
* Intracranial hypertension
* Chronic respiratory disease requiring oxygen therapy or mechanical ventilation at home
* Undrained pneumothorax or subcutaneous emphysema
* Patients for which death is deemed imminent and inevitable or patients with an underlying disease process with a life expectancy of less than 3 month
* Body mass index (BMI) \>40 kg/m2
* Pregnant or breastfeeding women
* Patients already enrolled in the IMPROVE-2 trial
* Participation in a confounding trial with mortality or PRF as the main endpoint
* Patient's or relative's refusal to participate
* Guardianship or trusteeship patient
* No affiliation to the Social Security system
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Clermont-Ferrand
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emmanuel Futier
Role: PRINCIPAL_INVESTIGATOR
CHU de Clermont-Ferrand
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University hospital
Angers, , France
Hospital
Annecy, , France
University hospital
Besançon, , France
University Hospital
Bordeaux, , France
Hospital
Chalon-sur-Saône, , France
University hospital
Clermont-Ferrand, , France
University hospital
Dijon, , France
University hospital
Grenoble, , France
University hospital
Le Mans, , France
University hospital
Lille, , France
University hospital
Lyon, , France
University hospital
Marseile, , France
Assistance Publique-Hôpitaux de Marseille
Marseille, , France
Institut Paoli Calmette
Marseille, , France
University hospital
Marseille, , France
University hospital
Montpellier, , France
University Hospital
Nantes, , France
University hospital
Nice, , France
University hospital
Nîmes, , France
Assistance Publique-Hôpitaux de Paris
Paris, , France
Hospital
Périgueux, , France
University hospital
Point A Pitre, , France
University hospital
Rennes, , France
University hospital
Saint-Etienne, , France
University hospital
Strasbourg, , France
Hospital
Suresnes, , France
University hospital
Toulouse, , France
Hospital
Valenciennes, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Futier E, De Jong A, Cirenei C, Godet T, Jabaudon M, Constantin JM, Grillot N, Bouzat P, Henry L, Margetis D, Lebuffe G, Garnier M, Lambert C, Pereira B, Jaber S; IMPROVE-2 Trial investigators. Personalized driving pressure-guided positive end-expiratory pressure in patients at risk of postoperative respiratory failure (IMPROVE-2): a multicenter, pragmatic, randomized clinical trial. Intensive Care Med. 2025 Oct;51(10):1797-1808. doi: 10.1007/s00134-025-08082-x. Epub 2025 Aug 21.
Khaled L, Godet T, Jaber S, Chanques G, Asehnoune K, Bourdier J, Araujo L, Futier E, Pereira B. Intraoperative protective mechanical ventilation in patients requiring emergency abdominal surgery: the multicentre prospective randomised IMPROVE-2 study protocol. BMJ Open. 2022 May 6;12(5):e054823. doi: 10.1136/bmjopen-2021-054823.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-A00265-52
Identifier Type: OTHER
Identifier Source: secondary_id
IMPROVE-2 study
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.